For instance, a rise in serum MMP-2 levels has been identified in advanced stages of nonsmall cell lung cancer (NSCLC) compared with nonmetastatic lung cancer and control subjects [29–31]. This evidence concerns the gene MMP2 and non-small cell lung carcinoma.